MedPath
NMPA Approval

Furosemide Oral Solution

国药准字H20249242

November 5, 2024

Drug Information

呋塞米口服溶液

口服溶液剂

60ml:0.6g

化学药品

November 5, 2024

Company Information

Applicant Company

北京市顺义区中北工业区(北石槽镇)

Manufacturing Company

北京市顺义区中北工业区(北石槽镇)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

呋塞米口服溶液 - NMPA 批准文号 | MedPath